Wyeth Pharmaceuticals tries to STOP your access to Bio-Identical Hormone Replacement Therapies (BHRT).

BHRT-A BATTLE FOR THE TRUTH

On October 16, 2005, Wyeth Pharmaceuticals, the maker of Premarin and Prempro, filed a "Citizens Complaint" with the Federal Drug Administration (FDA) requesting that compounding pharmacies be prohibited from providing bio-identical hormone therapies to their patients. As a practicing physician and trained pharmacist, I am deeply concerned that my patients' access to safe and efficacious bio-identical hormone replacement therapies (BHRT) could be at risk. Even more, I am horrified that Wyeth would so brazenly attempt to use its corporate wealth and power to twist the facts, manipulate the research and, ultimately, push their mercenary agenda through a federal governing body.

Click Here Read This Full Article from Dr. Randolph...

UPDATE

As of April 7, 2006, The FDA has received over 37,000 comments regarding the Wyeth complaint. At least 99.9% of the comments oppose Wyeth’s attempt to restrict women’s rights to choose bio-identical hormones. The FDA has rarely received a response of this magnitude and as a result, the comment period has been extended to May 4, 2006.

Click Here to Post Your Comments with the FDA...